Skip to main content
. Author manuscript; available in PMC: 2017 Jul 6.
Published in final edited form as: Lancet Oncol. 2016 Feb 6;17(3):299–308. doi: 10.1016/S1470-2045(15)00544-6

Figure 2. Time to RECIST response (confirmed and unconfirmed) and duration of response.

Figure 2

PD=progressive disease; PD-L1=programmed cell death ligand-1; RECIST=Response Evaluation Criteria In Solid Tumors.